We are pleased to announce two new additions to the ZPB team, David Rowley and Celine Parmentier.
David has joined as a board advisor and will be supporting the growth of the business, in particular, “deepening its reach into the pharmaceutical sector” through our expanded market access and insight offer, which launched last year. Prior to this role, David was founder/CEO of Huntsworth Health before going on to be co-founder and chief executive of Open Health.
Celine has joined the team as director of pharma services, and will lead our work with pharma companies. She has 10 years of experience in the pharmaceutical industry, including six years at healthcare comms agency Havas Lynx Group.
Zoe Bedford, CEO of ZPB Associates, said: “We are incredibly proud to have doubled the size of our business in the past 18 months, delivering outstanding work and award-winning campaigns. This growth and success underlines ZPB’s unique offer to our pharma, digital health and services clients. Appointing David to our board will accelerate this growth, marking the next stage in our ambitious growth strategy.
“We’re also delighted to welcome Celine to our team who already feels like a true ZPB-er. ZPB has a unique skillset that brings deep market insight, strategy and communications under one roof. This diversity of thinking and approach is fundamental to how we approach our work, and the creativity, energy and smart thinking that Celine brings to the team, amplifies this.”